These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27338972)

  • 21. Adolescent substance abuse and psychiatric comorbidities.
    Deas D; Brown ES
    J Clin Psychiatry; 2006 Jul; 67(7):e02. PubMed ID: 17107227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Better treatment for dual diagnosis patients.
    Schneier M
    Psychiatr Serv; 2000 Sep; 51(9):1079. PubMed ID: 10970906
    [No Abstract]   [Full Text] [Related]  

  • 23. Co-Occurring Disorders: A Challenge for Mexican Community-Based Residential Care Facilities for Substance Use.
    Marín-Navarrete R; Medina-Mora ME; Horigian VE; Salloum IM; Villalobos-Gallegos L; Fernández-Mondragón J
    J Dual Diagn; 2016; 12(3-4):261-270. PubMed ID: 27494051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The adolescent and substance abuse: current concepts.
    Greydanus DE; Patel DR
    Curr Probl Pediatr Adolesc Health Care; 2005 Mar; 35(3):78-98. PubMed ID: 15723035
    [No Abstract]   [Full Text] [Related]  

  • 25. Dual diagnosis of major mental illness and substance disorder: an overview.
    Drake RE; McLaughlin P; Pepper B; Minkoff K
    New Dir Ment Health Serv; 1991; (50):3-12. PubMed ID: 1886548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Enhancement to Improve Substance Abuse Outcomes in Persons With Co-Occurring Disorders.
    McGurk SR
    J Dual Diagn; 2016; 12(1):72-3. PubMed ID: 26828921
    [No Abstract]   [Full Text] [Related]  

  • 27. Dual diagnosis among physicians: a clinical perspective.
    Braquehais MD; Lusilla P; Bel MJ; Navarro MC; Nasillo V; Díaz A; Valero S; Padrós J; Bruguera E; Casas M
    J Dual Diagn; 2014; 10(3):148-55. PubMed ID: 25392289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Destination Matters More: Relapse following Hospital-Based Treatment of Substance Use Disorders With and Without Co-Occurring Disorders.
    Andreu M; Balcells-Olivero M; Alcaraz N; Marco O; Bueno L; Gual A; Barrio P
    J Dual Diagn; 2024; 20(2):111-121. PubMed ID: 38367999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance abuse with mental disorders: specialized public systems and integrated care.
    Burnam MA; Watkins KE
    Health Aff (Millwood); 2006; 25(3):648-58. PubMed ID: 16684728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consulting for substance abuse: mental disorders among adolescents and their parents.
    Hodgins S; Tengström A; Bylin S; Göranson M; Hagen L; Janson M; Larsson A; Lundgren-Andersson C; Lundmark C; Norell E; Pedersen H
    Nord J Psychiatry; 2007; 61(5):379-86. PubMed ID: 17990200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motivational Interviewing to Reduce Substance Use in Adolescents with Psychiatric Comorbidity.
    Brown RA; Abrantes AM; Minami H; Prince MA; Bloom EL; Apodaca TR; Strong DR; Picotte DM; Monti PM; MacPherson L; Matsko SV; Hunt JI
    J Subst Abuse Treat; 2015 Dec; 59():20-9. PubMed ID: 26362000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-morbid substance misuse and mental health problems: policy and practice in Scotland.
    Baldacchino A
    Am J Addict; 2007; 16(3):147-59. PubMed ID: 17612817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical management of co-morbidity.
    Pols RG
    Alcohol Alcohol Suppl; 1994; 2():485-90. PubMed ID: 8974372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pain: the new co-morbidity.
    Athanasos P
    Aust Nurs J; 2007 Nov; 15(5):41. PubMed ID: 18044246
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual diagnosis and forensic care. Are the needs of service users being met?
    Young A
    J Psychiatr Ment Health Nurs; 2006 Feb; 13(1):117-24. PubMed ID: 16441402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.